Amyris, Inc. is an industrial biotechnology company headquartered in Emeryville, California, founded in 2003. The company specializes in synthetic biology, using precision fermentation and engineered microorganisms to convert plant sugars, primarily from sugarcane, into renewable molecules and specialty chemicals.
Amyris develops and manufactures bio-based ingredients for applications in cosmetics, personal care, flavors, fragrances, food, pharmaceuticals, and performance materials. Key products include farnesene-derived compounds such as squalane and squalene, as well as sweeteners like Reb M and biosilica. It operates advanced fermentation facilities, including plants in Brazil, to produce these sustainable alternatives to petroleum-based chemicals at commercial scale.
Initially focused on artemisinin for antimalarial drugs, Amyris has expanded into a vertically integrated platform for custom renewable chemistry, partnering with firms like WACKER on bio-based functional ingredients for cosmetics.
Also known as Amyris Biotechnologies, Inc..
None yet. When a new project in the record names Amyris as owner, partner or investor, it shows here.
Develop bio-based functional ingredients for cosmetics; expand silicone range with renewable raw materials; test novel molecules and production integration.
